{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:20:13Z","timestamp":1753888813835,"version":"3.41.2"},"reference-count":39,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202062008","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T15:06:46Z","timestamp":1581088006000},"source":"Crossref","is-referenced-by-count":6,"title":["Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil"],"prefix":"10.1590","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-5831","authenticated-orcid":false,"given":"Camila Melo","family":"Picone","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Carvalho","family":"Freitas","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana B.","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-3088","authenticated-orcid":false,"given":"Vivian Iida","family":"Avelino-Silva","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"year":"2019","series-title":"Global tuberculosis report 2019","key":"ref1"},{"series-title":"Programa de Controle da Tuberculose do Estado de S\u00e3o Paulo. Plano estadual pela elimina\u00e7\u00e3o da tuberculose: 2018 a 2021","key":"ref2"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","article-title":"III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner D","year":"2017","journal-title":"Ann Intern Med"},{"year":"2018","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","key":"ref5"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142290","article-title":"Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Ayele HT","year":"2015","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel C","year":"2015","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/23744235.2016.1262059","article-title":"Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review","volume":"49","author":"Bruins WS","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciu849","article-title":"Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB\/HIV in Rio (THRio) study","volume":"60","author":"Golub JE","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1097\/QAI.0000000000000497","article-title":"Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV\/AIDS: a review of the literature","volume":"68","author":"Briggs MA","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-1293.2009.00730.x","article-title":"Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV\/AIDS","volume":"10","author":"Gutierrez EB","year":"2009","journal-title":"HIV Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.aids.0000391022.95412.a6","article-title":"The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB\/HIV in Rio (THRio) study","volume":"24","author":"Durovni B","year":"2010","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.aids.0000391009.95149.ec","article-title":"Isoniazid preventive therapy for HIV-infected people: evidence to support implementation","volume":"24","author":"Eldred LJ","year":"2010","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1473-3099(13)70187-7","article-title":"Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial","volume":"13","author":"Durovni B","year":"2013","journal-title":"Lancet Infect Dis"},{"year":"2018","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para manejo da infec\u00e7\u00e3o pelo HIV em adultos","key":"ref15"},{"key":"ref16","first-page":"829","article-title":"Preparation of purified tuberculin RT 23","volume":"19","author":"Magnusson M","year":"1958","journal-title":"Bull World Health Organ"},{"year":"2011","series-title":"Tratamento diretamente observado (TDO) da tuberculose na aten\u00e7\u00e3o b\u00e1sica: protocolo de enfermagem","key":"ref17"},{"key":"ref18","first-page":"21","article-title":"Teste tubercul\u00ednico: dilui\u00e7\u00e3o padronizada do PPD Rt 23 no Brasil","volume":"12","author":"Carneiro AJ","year":"1986","journal-title":"J Pneumol"},{"year":"2014","series-title":"T\u00e9cnicas de aplica\u00e7\u00e3o e leitura da prova tubercul\u00ednica","key":"ref19"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5501\/wjv.v4.i2.105","article-title":"Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons","volume":"4","author":"Akolo C","year":"2015","journal-title":"World J Virol"},{"key":"ref21","first-page":"1","article-title":"Brasil livre da tuberculose: evolu\u00e7\u00e3o dos cen\u00e1rios epidemiol\u00f3gicos e operacionais da doen\u00e7a","volume":"50","year":"2019","journal-title":"Bol Epidemiol"},{"edition":"2\u00aa","year":"2019","series-title":"Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","key":"ref22"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5123\/S1679-49742012000400013","article-title":"Indica\u00e7\u00e3o da prova tubercul\u00ednica e infec\u00e7\u00e3o latente da tuberculose em HIV-positivos, munic\u00edpio de Blumenau, Estado de Santa Catarina, Brasil, 2004-2009","volume":"21","author":"Siqueira KZ","year":"2012","journal-title":"Epidemiol Serv Saude"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.aids.0000391021.18284.12","article-title":"Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study","volume":"24","author":"Lester R","year":"2010","journal-title":"AIDS"},{"series-title":"Brasil est\u00e1 h\u00e1 mais de um ano sem conseguir comprar testes para diagnosticar tuberculose latente","key":"ref25"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)62335-7","article-title":"Shortage of purified protein derivative for tuberculosis testing","volume":"384","author":"Tebruegge M","year":"2014","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.15585\/mmwr.mm6824a4","article-title":"Nationwide shortage of tuberculin skin test antigens: CDC recommendations for patient care and public health practice","volume":"68","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5588\/ijtld.16.0836","article-title":"Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi","volume":"22","author":"Little KM","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5588\/ijtld.15.0805","article-title":"Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia","volume":"20","author":"Ayele HT","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","first-page":"249","article-title":"Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil","volume":"15","author":"Saraceni V","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"ref31","first-page":"551","article-title":"Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment","volume":"14","author":"Trajman A","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311x00050916","article-title":"Infec\u00e7\u00e3o latente por tuberculose entre pessoas com HIV\/AIDS, fatores associados e progress\u00e3o para doen\u00e7a ativa em munic\u00edpio no Sul do Brasil","volume":"33","author":"Santos DT","year":"2017","journal-title":"Cad Saude Publica"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5588\/ijtld.17.0370","article-title":"Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi","volume":"22","author":"Thindwa D","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref34","first-page":"719","article-title":"Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil","volume":"13","author":"Machado Jr A","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf H","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01363-2018","article-title":"Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support","volume":"52","author":"Nsengiyumva N","year":"2018","journal-title":"Eur Respir J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/0074-02760140458","article-title":"Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry method in a randomised, crossover study","volume":"110","author":"Daher A","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/0037-8682-0156-2014","article-title":"Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence","volume":"48","author":"Vidal JS","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bjid.2015.10.007","article-title":"Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil","volume":"20","author":"Kussen GM","year":"2016","journal-title":"Braz J Infect Dis"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v62\/1678-9946-rimtsp-62-S1678-9946202062008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T10:32:36Z","timestamp":1611397956000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652020000100203&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":39,"alternative-id":["S0036-46652020000100203"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202062008","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e8"}}